Prevalence of obesity in patients with acute hepatitis; is severe obesity a risk factor for fulminant hepatitis in Japan?

Hepato-Gastroenterology

Volumn 52, Issue 61, 2005, Pages 180-182

  Kanda, Tatsuo ^a,b   Yokosuka, Osamu ^a   Hiraide, Akira ^a   Kojima, Hiroshige ^a   Honda, Arata ^a   Fukai, Kenichi ^a   Imazeki, Fumio ^a   Nagao, Keiichi ^b   Saisho, Hiromitsu ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Fulminant hepatitis; Japan; Obesity

Indexed keywords

ACUTE HEPATITIS; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ACUTE DISEASE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; FEMALE; HEPATITIS; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 14144254702     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. O'Grady JG, Alexander GJ, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1991; 97:439-445.
2. Takahashi Y, Kumada H, Shimizu M, et al: A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation. Hepatology 1994; 19:1065-1071.
3. Hwang SJ, Luo JC, Chu CW, et al: Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol 2001; 16:190-195.
4. Marchesini G, Bugianesi E, Forlani G, et al: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37:917-923.
5. Iturriaga H, Bunout D, Hirsch S, Ugarte G: Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutr 1988; 47:235-238.
6. Kontorinins N, Dieterich D: Hepatotoxicity of antiretroviral therapy. AIDS Rev 2003; 5:36-43.
7. Moult PJ, Sherlock S: Halothane-related hepatitis. A clinical study of twenty-six cases. Q J M 1975; 44:99-114.
8. Marthurin P, Durand F, Ganne N, et al: Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995; 109:1682-1684.
9. Kanda T, Yokosuka O, Imazeki F, Saisho H: Acute hepatitis C virus infection, 1986-2001: a rare cause of fulminant hepatitis in Chiba, Japan. Hepatogastroenterology. 2004; 51:556-558.
10. Kanda T, Yokosuka O, Fujiwara K, et al: Fulminant hepatic failure associated with triazolam. Dig Dis Sci 2002; 47:1111-1114.
11. Health and Welfare Statistics Association: Journal of health and welfare statistics. Tokyo, Japan: Kousaidou, 2002; pp. 464. (In Japanese)
12. Hade AM, Shine AM, Kennedy NP, McCormick PA: Both under-nutrition and obesity increase morbidity following liver transplantation. Ir Med J 2003; 96:140-142.
13. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36:54-59.
14. Teran JC: Nutrition and liver diseases. Curr Gastroenterol Rep 1999; 1:335-340.